Сингапур - Енглески - HSA (Health Sciences Authority)

eyesation singapore private limited - ophthalmology - for daily wear to correct visual acuity in aphakic.

Сингапур - Енглески - HSA (Health Sciences Authority)

eyesation singapore private limited - ophthalmology - for daily wear to correct visual acuity in aphakic.

Сингапур - Енглески - HSA (Health Sciences Authority)

eyesation singapore private limited - ophthalmology - for daily wear to correct visual acuity in aphakic.

Сингапур - Енглески - HSA (Health Sciences Authority)

emergo singapore consulting private limited - ophthalmology - soft contact lenses are for daily wear to correct visual acuity in non-aphakic persons with non-diseased eyes with myopia. the lens is available clear or tinted.

Сингапур - Енглески - HSA (Health Sciences Authority)

emergo singapore consulting private limited - ophthalmology - soft contact lenses are for daily wear to correct visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia. the lens may be worn by persons who exhibit refractive astigmatism of 0.50 diopters or less where the astigmatism does not interfere with visual acuity.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

seqirus inc. - influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated) (unii: b8p3xn76w4) (influenza a virus a/georgia/12/2022 cvr-167 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) - unii:n8jks3vk2a), influenza a virus a/darwin/11/2021 (h3n2) antigen (mdck cell derived, propiolactone inactivated) (unii: pv9k2r8hrm) (influenza a virus a/darwin/11/2021 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) - unii:c6pm4nxj3 - flucelvax quadrivalent is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes a and types b contained in the vaccine. flucelvax quadrivalent is approved for use in persons 6 months of age and older. [see clinical studies (14)] do not administer flucelvax quadrivalent to anyone with a history of severe allergic reaction (e.g. anaphylaxis) to any component of the vaccine [see description (11)] . risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data collected in a prospective pregnancy exposure registry from 665 women vaccinated with flucelvax quadrivalent showed no evidence of a vaccine-associated increase in the risk of major birth defects and miscarriages when flucelvax quadrivalent is administered during any trime

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

stay in touch solutions pty ltd -

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

havenhall pty ltd - ethyl butylacetylaminopropionate - impregnated wet tissue - ethyl butylacetylaminopropionate amino acid-ester active 75.0 g/kg - household insecticide - pest control - personal use - mosquito | adult mosquitoes

Нигерија - Енглески - NAFDAC (National Agency for Food and Drugs Administration and Control)

freeze dried substance of georgia (intermediate) strian of ibd virus

Белгија - Енглески - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharmagal bio spol. s.r.o. - newcastle disease virus (inactivated) ; fowl adenoviruses type 8 (inactivated) >= 24,7 elisa u; pigeon herpes virus 1 (inactivated) >= 38,1 elisa u - emulsion for injection - paramyxovirus (newcastle disease virus), inactivated; pigeon herpes virus, inactivated; poultry adenovirus type 8, inactivated - inactivated viral vaccines - pigeon